Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

Date
ASCO invites interested stakeholders to submit comments on draft guideline recommendations on Management of Osteoporosis in Survivors of Adult Cancers between February 7 - February 21. This open comment process provides greater transparency in the guideline development process and the opportunity for key stakeholders to provide feedback before the document’s finalization and publication. Participate now.  
On January 8, 2019 ASCO published standards on the safe handling of hazardous drugs in the Journal of Clinical Oncology (JCO).
On February 6, 2019, the Food and Drug Administration approved caplacizumab-yhdp (CABLIVI®, Ablynx NV) for adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy. Read more. 
Oncology practices have an opportunity to learn how they compare to others on key business and operational benchmarks through ASCO’s annual Survey of Oncology Practice Operations. The survey, which opens today, reviews the current state of business and operational issues in oncology and is part of ASCO’s continued efforts to help oncology practices navigate the evolving cancer care delivery system.
From February 11-12 in Washington, DC, the National Cancer Policy Forum of the National Academies is hosting a workshop, “Developing and Sustaining an Effective and Resilient Oncology Careforce.”
ASCO has been informed that some oncology practices and providers in the Merit-Based Incentive Payment System (MIPS) have received inaccurate payment adjustments as a result of Medicare Part B drug costs incorrectly being included in the adjustments. The Centers for Medicare & Medicaid Services (CMS) is also aware of the error and is working to resolve the issue. ASCO is in contact with CMS and will continue to keep members informed as a solution is implemented.
Encourage your patients to subscribe and listen to Cancer.Net podcasts for expert insights on popular cancer-related topics like understanding liquid biopsy, fasting during cancer treatment, and much more.  Subscribe today!
Share ASCO Answers fact sheets with your patients so they can continue to learn after their visits. Direct, easy to understand, and in a convenient single-page format, ASCO Answers fact sheets introduce patients and their caregivers to types of cancer and cancer-related topics, including treatments and side effects. ASCO Answers products ship for free inside the U.S. ASCO Members save 20%. Order Today!